Skip to main content
TeamingIndex
Unclaimed profileSeeded from SAM.gov and USAspending public records
Claim this profileCapability statement (.md)

GILEAD SCIENCES INC

UEIFPJMGUK1BYH8CAGE0SFJ8NAICS325412
  • SAM active
  • No verified credentials yet
  • CMMCNot on file
  • SPRSNone
  • FCLVisible to paid members

Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works

36-mo obligations
$145.9K
Awards on record
10
Contract vehicles
0
Verified credentials
0

Compliance posture: unverified (SAM.gov baseline only)

GILEAD SCIENCES INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0

Claim this profile

About GILEAD SCIENCES INC

GILEAD SCIENCES INC is a SAM.gov-registered entity based in FOSTER CITY, CA 94404-1147. UEI FPJMGUK1BYH8; CAGE 0SFJ8; primary NAICS 325412. Compliance posture not provided. Active SAM registration.
Headquarters
FOSTER CITY, CA 94404-1147

Identifiers

UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.

  • UEIFPJMGUK1BYH8
  • CAGE0SFJ8

Capabilities & differentiators

No capability narrative yet

The company has not published a capability narrative. Its SAM.gov registration, NAICS codes and award history are below.
Is this your company? Claim it

Compliance posture

Every credential shows who vouches for it: verified by TeamingIndex, or self-attested by the contractor.

No compliance posture published yet

Compliance facts appear once the company claims this profile and publishes them.
Is this your company? Claim it

Facility clearance

Facility clearance: visible to paid members

Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans

Past performance

Recompete RadarLearn more about past performance
Prime awards from USAspending.gov (FPDS), synced nightly. Recompete windows use the potential end date (base plus all options).
36-month obligations
$145.9K
Awards on record
10
Top funding agencies
Department of Veterans Affairs

Awards

  • 36C26125N0499

    Completed: Period of performance ended Jul 14, 2025

    LENACAPAVIR (SUNLENCA)

    Department of Veterans Affairs

    Obligated
    $14.9K
    Period of performance
    May 14, 2025 – Jul 14, 2025

  • 36C26025F0137

    Completed: Period of performance ended Feb 18, 2025

    SUNLENCA 300MG TAB,PKT,5

    Department of Veterans Affairs

    Obligated
    $3.1K
    Period of performance
    Jan 28, 2025 – Feb 18, 2025

  • 36C26025F0134

    Completed: Period of performance ended Feb 15, 2025

    SUNLENCA 300MG TAB,PKT,4

    Department of Veterans Affairs

    Obligated
    $2.5K
    Period of performance
    Jan 23, 2025 – Feb 15, 2025

  • 36C24524N0911

    Completed: Period of performance ended Sep 13, 2024

    SULENCA INJ

    Department of Veterans Affairs

    Obligated
    $14.9K
    Period of performance
    Sep 12, 2024 – Sep 13, 2024

  • 36C26024F0466

    Completed: Period of performance ended Jul 8, 2024

    LENACAPAVIR

    Department of Veterans Affairs

    Obligated
    $47.8K
    Period of performance
    Jul 1, 2024 – Jul 8, 2024

  • 36C26024F0440

    Completed: Period of performance ended Jul 5, 2024

    LENACAPAVIR TABS & INJECTIONS

    Department of Veterans Affairs

    Obligated
    $47.8K
    Period of performance
    Jun 7, 2024 – Jul 5, 2024

  • 36C24524N0504

    Completed: Period of performance ended Apr 15, 2024

    SULENCA INJ AND TABLETS

    Department of Veterans Affairs

    Obligated
    $14.9K
    Period of performance
    Apr 15, 2024 – Apr 15, 2024

  • 36C26320F0048

    Completed: Period of performance ended May 14, 2023

    PHARMACEUTICAL - LETAIRIS 5MG TABLET

    Department of Veterans Affairs

    Obligated
    $9.8K
    Period of performance
    Mar 12, 2020 – May 14, 2023

  • 36C25921F0343

    Completed: Period of performance ended Jul 2, 2021

    REMDESIVIR VEKLURY 100 MG

    Department of Veterans Affairs

    Obligated
    $0
    Period of performance
    Jun 24, 2021 – Jul 2, 2021

  • 75P00119C00080

    Completed: Period of performance ended Oct 29, 2020

    OFFICE OF INFECTIOUS DISEASE AND HIV/AIDS POLICY (OIDP): ENDING THE HIV EPIDEMIC - PRE-EXPOSURE PROPHYLAXIS (PREP) IMPLEMENTATION AND…

    Department of Health and Human Services · Office of the Assistant Secretary for Administration

    Obligated
    $1.4M
    Period of performance
    Sep 30, 2019 – Oct 29, 2020

Contract vehicles

Learn more about GWACs, IDIQs and contract vehicles

No contract vehicles on file

This company has not listed GWAC, IDIQ, GSA Schedule or OTA consortium holdings.
Browse vehicle holders

Proven teaming graph

Learn more about sub-award reporting (FSRS)
Who GILEAD SCIENCES INC has actually worked with, from sub-awards that prime contractors report to the government. Use it to see which primes already trust this company.

No sub-award reports yet

Prime contractors report first-tier subcontracts of $30,000 or more. None name this company yet, which is common for companies that mostly win prime contracts or work below the reporting threshold.
See where agencies spend

Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.

SBIR/STTR portfolio

Learn more about SBIR/STTR Phase IIIAbout SBIR/STTR (opens in a new tab)
Small Business Innovation Research and Technology Transfer awards: early-stage federal R&D money this company has won.

SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects

Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.

Awards on record
6 awards
Total awarded
$1,230,000
By phase
  • SBIR Phase I: 4
  • SBIR Phase II: 2
By agency
  • Department of Health and Human Services: 6
By year
  • 1994: 1
  • 1993: 1
  • 1992: 3
  • 1989: 1

Awards (most recent first)

  • OLIGONUCLEOTIDES BEARING FORMACETAL LINKAGES AGAINST HIV

    SBIR Phase II · Department of Health and Human Services · 1994 · $530,000

  • NOVEL INHIBITORS OF THROMBIN

    SBIR Phase II · Department of Health and Human Services · 1993 · $500,000

  • OLIGONUCLEOTIDES BEARING FORMACETAL LINKAGES AGAINST HIV

    SBIR Phase I · Department of Health and Human Services · 1992 · $50,000

  • PERMEATION-ENHANCED PRIMER-DISRUPTING ANTIVIRAL AGENTS

    SBIR Phase I · Department of Health and Human Services · 1992 · $50,000

  • NOVEL INHIBITORS OF THROMBIN

    SBIR Phase I · Department of Health and Human Services · 1992 · $50,000

  • RIBOZYME-LIKE ANALOGUES OF OLIGORIBONUCLEOTIDES

    SBIR Phase I · Department of Health and Human Services · 1989 · $50,000

Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026

FedRAMP offerings

Learn more about the FedRAMP Marketplace
Cloud services this company lists on the FedRAMP Marketplace, the government's record of cloud authorizations.

No FedRAMP Marketplace listing

No FedRAMP Marketplace listing is linked to this company. Cloud providers appear here automatically once FedRAMP lists their offering.
Find FedRAMP-authorized companies

Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded

Exclusions & screening

Exclusions about SAM.gov exclusionsScreening list about the Consolidated Screening List
Checks a prime runs before teaming: SAM.gov exclusions (debarment and suspension) and the government's Consolidated Screening List for export and sanctions lists.

SAM.gov exclusions

Not yet checked against SAM.gov exclusions.

Search exclusions on SAM.gov (opens in a new tab)

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.

Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded

Consolidated Screening List

No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).

The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.

Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026

GSA CALC+ rate benchmark

Learn more about GSA CALC+ labor rates
Hourly ceiling rates this company was awarded on GSA contracts, compared with the market for similar labor categories. Ceiling rates are the most an agency can be charged, not prices paid.

No GSA CALC+ rates on record

Companies with a GSA Multiple Award Schedule contract appear here after CALC+ publishes their awarded labor rates.
See GSA MAS holders

Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded

NAICS, PSC & socio-economic status

Learn more about NAICS size standards
Industry codes and small-business programs reported in SAM.gov.

NAICS codes

  • 325412Pharmaceutical Preparation ManufacturingPrimary

SAM.gov does not report this entity as small under any listed NAICS code.

Socio-economic status

No socio-economic certifications reported in SAM.gov.

Product & service codes (PSC)

No PSC codes reported.

Teaming preferences

Learn more about teaming agreements and joint ventures

This company has not published teaming preferences.

SAM.gov teaming eligibility: Eligible to be proposed as a team member: active SAM.gov registration and no exclusion.

Business development contact

No BD contact published

Contact details appear once the company claims this profile.
Is this your company? Claim it

Corporate hierarchy

Affiliation & size about affiliation and size
Immediate parent and highest-level owner as reported in SAM.gov.

No parent entity reported in SAM.gov.

SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.

Data sources & provenance

Who stands behind each fact on this page, and how to correct it.

  • SAM.gov

    Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.

  • USAspending.gov

    Prime award history and obligations (FPDS), synced nightly.

  • The contractor

    Nothing yet: this profile has not been claimed by the company.

  • TeamingIndex verification

    Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.

Corrections

Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)

Machine-readable: capability.md schema.org JSON-LD embedded in this page.

Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.

Teaming

Ready to team with GILEAD SCIENCES INC?

Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.

Claim this profileCapability statement (.md)